PCK-3145

N/A

Report date: 2022/08/30 20:00:42
NME

Base Information

Drug NamePCK-3145
Drug Alias NamePSP-94 (31-45)PCK-3145
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsAngiogenesis inhibitorsGelatinases inhibitors
TargetsGelatinases
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAmbrilia Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmbrilia Biopharma Inc
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksDrugBank